TNFRSF9 and Sepsis: Recombinant CD137-Fc improved the recovery of mice from Gram-negative Acinetobacter pneumonia in the immunosuppressive phase of sepsis, suggesting a protective role of CD137 in Gram-negative infection and the hypoinflammatory state [13].